Much progress in the fight against Covid-19 | Health

05/14/2020 Health, World



[ad_1]

Dutch discovered antibodies that could neutralize Covid-19

Scientists at Utrecht University and Erasmus Medical Center in the Netherlands have discovered that the antibodies can neutralize the SARS-CoV-2 virus that causes Covid-19. The findings have just been published in the journal. Nature.
Although more time is needed to assess whether this antibody can protect or reduce the effect of Covid-19 in humans, experts say, the study’s groundbreaking results have sparked. Much hope for the development of future vaccines or therapies.

Japan tests favipiravir global

Favipiravir, a drug that prevents the virus from multiplying in cells, was sold under the brand name Avigan in 2014 by Toyama Chemical (Japan). Favipiravir has been approved by the World Health Organization (WHO) to combat Ebola in Africa.
When the outbreak began in Wuhan and Shenzhen, China, favipiravir was added to the treatment regimen and yielded positive results, helping to cut recovery time in half compared to patients who did not. using medicine Other countries, such as the United States, India, and Italy, are also testing favipiravir to treat Covid-19.

The CNBC channel in the first week of May quoted Japanese Foreign Minister Toshimitsu Motegi as saying that the land of the rising sun will give favipiravir free to 43 of the 80 countries interested in the drug. Estonia is the first country to receive favipiravir from Japan, and the drug is expected to arrive in the country on May 18.

The Russian Direct Investment Fund (RDIF) announced on August 13 that favipiravir had shown promising results in initial clinical trials in the country. 60% of the 40 Covid-19 patients who received favipiravir were negative for SARS-CoV-2 after 5 days.

United States estimates incubation period

The world’s leading medical journal Annals of internal medicine of the American Doctors Association in 5.5 published results of the Covid-19 incubation period.

According to statistics, the average incubation period is estimated to be 5.1 days and the time to develop symptoms is 11.5 days. These estimates are generally consistent with previously known human coronaviruses, including SARS (5-day average) and MERS (5-7 day average).

The study results help support recommendations for isolation or active surveillance for people who are likely to be exposed to SARS-CoV-2. Previously, the WHO issued a recommendation that Covid-19 could be incubated for 3-14 days.

Korea studies two new drugs

Scientists at the Korean Pasteur Institute examined 48 SARS-CoV-2 resistant drugs that were approved by the United States Food and Drug Administration (FDA) and discovered two potential drugs. Information published in the magazine. Antimicrobial agents and chemotherapy of the American Society for Microbiology. An anthelmintic drug, niclosamide, has been shown to be “extremely potent” against SARS-CoV-2 and MERS-CoV. Follow The herald of KoreaNiclosamide is believed to be 40 times more potent against parasites than remdesivir. Although the strength of the drug has been shown, doctors have problems that humans cannot absorb in pill form. Global pharmaceutical companies are competing to find the correct way to introduce the drug into their bodies.

The other is ciclesonide, an ingredient in inhaled asthma medicine sold in pharmacies under the name of Alvesco. With its proven anti-inflammatory activity, ciclesonide can be a powerful drug that helps control SARS-CoV-2.




[ad_2]

Designed by Tricksfast Solutions
© Copyright 2024, All Rights Reserved